Filing Flows › Alkermes (ALKS) › How it makes money
How Alkermes (ALKS) makes money
Alkermes (ALKS) made $480M of revenue in the third quarter 2026 (Q3 2026), +607% from a year earlier. Product brought in $417M (87%); Royalty brought in $63.2M (13%). Of every dollar of revenue, 7¢ was left as operating profit, 3¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product | $417M | 86.9% | +1% | — |
| ↳ Vivitrol | $128M | 26.6% | +2% | +5% |
| ↳ Aristada and Aristada Initio | $104M | 21.6% | +7% | +6% |
| ↳ LYBALVI | $95.9M | 20.0% | +2% | -2% |
| ↳ LUMRYZ | $89.9M | 18.7% | -7% | — |
| Royalty | $63.2M | 13.1% | -0.4% | -7% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $480M | 100.0% |
| Operating profit | $36.0M | 7.5% |
| Net earnings | $16.3M | 3.4% |
| Operating cash flow | $93.5M | 19.5% |
| Free cash flow | $90.1M | 18.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $480M | +22% |
| Q2 2026 | $496M | +27% |
| Q1 2026 | $393M | +28% |
| Q4 2025 | $385M | -11% |
| Q3 2025 | $394M | +4% |
| Q2 2025 | $391M | -2% |
| Q1 2025 | $307M | -12% |
From Alkermes' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Alkermes make money?
Alkermes (ALKS) made $480M of revenue in the third quarter 2026 (Q3 2026), +607% from a year earlier. Product brought in $417M (87%); Royalty brought in $63.2M (13%). Of every dollar of revenue, 7¢ was left as operating profit, 3¢ was left as net earnings.
What is Alkermes' biggest business?
Product: $417M in the third quarter 2026, 87% of revenue.
What is Alkermes' profit margin?
Net earnings were $16.3M, 3.4% of revenue, in the third quarter 2026; the operating margin was 7.5%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.